Why is the Telix Pharmaceuticals (ASX:TLX) share price plunging 14%?

What's going on with the ASX 200 biotech's share price today?

| More on:
man grimaces next to falling stock graph

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Telix Pharmaceuticals share price has fallen nearly 14% to trade at $4.09 at the time of writing
  • The fall comes despite analysts' believing the company's stock is worth looking at
  • The market has heard price sensitive news from the company twice this week. However, it seemingly wasn't enough to turn its share price's ongoing tumble around

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is cratering today despite the company's silence.

The plunge follows yesterday's tumble that saw the biotech stock close 7.42% lower.

At the time of writing, the Telix Pharmaceuticals share price is $4.09, 13.71% lower than its previous close.

For context, the S&P/ASX 200 Index (ASX: XJO) is currently up 0.45%.

The company's fall comes despite analysts at Wilsons flagging they're still bullish on the company. They've noted its a stock worth looking at, reports The Motley Fool Australia's Tony Yoo.

So, without further ado, let's take a look at what could be weighing on the ASX 200 newbie's shares on Friday.

What's dragging on the Telix Pharmaceuticals share price?

The Telix Pharmaceuticals share price is in the red once more today despite no news having been released by the company. However, the market did hear from it on both Tuesday and Wednesday.

First, the company announced that the buildout of its Beligian radiopharmaceutical production facility has begun.

To fund the development, the company has secured an $18.2 million loan and applied for $3 million of grants. The first stage of the build is expected to cost $21.2 million.

Then, it released news its glioblastoma multiforme therapy candidate TLX101 has progressed to the next stage of clinical development – a phase 1 dose escalation study.

The Telix Pharmaceuticals share price gained 1.4% on Tuesday and 2.2% on Wednesday, before plummeting towards the end of the week.

It's a similar story to the recent performance of the S&P/ASX 200 Health Care Index (ASX: XHJ). It fell 0.61% yesterday and it's currently down another 0.71%. Telix Pharmaceuticals is the sector's weight today.

Also worth noting, the company's short-selling interest has risen from approximately 1% this time last month to 2.25% as of the most recent data. That means more market participants are expecting the stock to go lower.

So far since last Friday's close, the company's stock has tumbled nearly 20%. It's worth noting, it gained 4.5% last week.

Though, the Telix Pharmaceuticals share price is likely used to being in the red. It has fallen 50% since the start of 2022. Still, it's only 9% lower than it was this time last year.

That's despite the company taking the place of the formerly-listed Sydney Airport in the ASX 200 in February.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why this top broker expects CSL shares to surge 26%

A leading broker foresees a big rebound ahead for CSL shares. But why?

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

Guess which ASX All Ords stock is jumping on big US news

This small cap is catching the eye on Thursday. But why?

Read more »

three excited doctors with hands in the air
Healthcare Shares

Two ASX healthcare shares that could be set to double

This broker has buy recommendations on these two shares. 

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Telix shares jump 7% on big US news

Let's see what is getting investors excited on Wednesday.

Read more »

An older gentleman leans over his partner's shoulder as she looks at a tablet device while seated at a table.
Healthcare Shares

Macquarie tips 28% upside for this ASX healthcare stock

The broker expects big things from this New Zealand retirement village developer and operator.

Read more »

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
Healthcare Shares

$10,000 invested in these ASX healthcare shares 5 years ago is now worth…

These healthcare stocks have brought big returns for investors 

Read more »

A man wearing a white coat and glasses is wide-mouthed in surprise.
Healthcare Shares

Guess which ASX 300 stock is crashing 55% today

What's going on with this stock? Let's see why investors are hitting the sell button.

Read more »

Woman serving customer in pharmacy.
Healthcare Shares

Up 132% in a year, are Sigma Healthcare shares still a good buy post the Chemist Warehouse merger?

After gaining 132% in 12 months, it too late to buy Sigma Healthcare shares today?

Read more »